Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weber

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsValory Pavlik, Christopher J Weber, Joseph C Masdeu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 21, 2020
Active immunotherapy and alternative therapeutic modalities for Alzheimer's diseaseStacie Weninger, Bjorn Sperling, Robert Alexander, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus reportGreg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCharles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (New York, N. Y.)|September 5, 2020
The pathway to secondary prevention of Alzheimer's diseaseEric McDade, Martin M Bednar, H Robert Brashear, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Clinical ManifestationsValory Pavlik, Christopher J Weber, Joseph C Masdeu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2023
Decision making in clinical trials: Interim analyses, innovative design, and biomarkersKathleen A Welsh-Bohmer, Geoffrey A Kerchner, Shobha Dhadda, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 21, 2020
Active immunotherapy and alternative therapeutic modalities for Alzheimer's diseaseStacie Weninger, Bjorn Sperling, Robert Alexander, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 12, 2020
Advancing combination therapy for Alzheimer's diseaseStephen P Salloway, Jeff Sevingy, Kumar Budur, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 3, 2025
Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practiceClifford R Jack, Ana Graf, Samantha C Burnham, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 22, 2024
Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: Navigating clinician-patient engagementDorene M Rentz, Paul S Aisen, Alireza Atri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 30, 2021
Committee on High-quality Alzheimer's Disease Studies (CHADS) consensus reportGreg A Jicha, Erin L Abner, Steven E Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumCharles C Windon, Constantine Gatsonis, Justin Romanoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 8, 2025
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging WorkgroupGil D Rabinovici, David S Knopman, Javier Arbizu, et al.
Pageof 4